Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53 family genes: structural comparison, expression and mutation.

S Ikawa1, A Nakagawara, Y Ikawa

  • 1Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Cell Death and Differentiation
|January 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BMCC1, which is an interacting partner of BCL2, attenuates AKT activity, accompanied by apoptosis.

Cell death & disease·2015
Same author

Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation.

Oncogene·2014
Same author

High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients.

British journal of cancer·2013
Same author

RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma.

Oncogene·2013
Same author

Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.

Cell death & disease·2013
Same author

Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation.

Oncogene·2012

The p51/p63 gene, found in skeletal muscle, plays a role in cell differentiation and apoptosis, distinct from p53. Its limited mutations in lung cancer suggest it

Area of Science:

  • Molecular Biology
  • Cancer Genetics
  • Cellular Differentiation

Background:

  • The p53-related genes, p51/p63 and p73, are crucial regulators of cellular processes.
  • p51/p63 exhibits tissue-specific expression, notably high in skeletal muscle.
  • Understanding the functional and structural differences between p51/p63, p73, and p53 is essential for comprehending their roles in cell biology and disease.

Purpose of the Study:

  • To compare the structural features and biological functions of p51/p63 and p73.
  • To investigate the role of p51A (TAp63gamma) in skeletal muscle differentiation.
  • To elucidate the functional relationship between p51/p63, p73, and p53, particularly in apoptosis and oncogenesis.

Main Methods:

  • Isolation of p51/p63 and p73 genes from cDNA libraries.

Related Experiment Videos

  • Reverse transcriptase-polymerase chain reaction (RT-PCR) for tissue-specific expression analysis.
  • Functional assays including erythrodifferentiation and apoptosis induction in erythroleukemia cell lines.
  • Yeast two-hybrid assays for protein-protein interaction analysis.
  • Mutation and loss of heterozygosity (LOH) analysis in human tumors.

    • Main Results:

    • High expression of p51A (TAp63gamma) in skeletal muscle and its induction during myoblast differentiation.
    • p51A induced erythrodifferentiation and apoptosis in specific erythroleukemia cell lines.
    • Protein interaction studies indicated functional distance between p51 and p53.
    • Limited mutations (4 in 80 cases) of p51/p63 in non-small cell lung carcinomas, suggesting it's not a typical tumor suppressor.

    Conclusions:

    • p51/p63 is functionally distinct from p53, with unique roles in cell differentiation and apoptosis.
    • p51/p63 is unlikely to be a Knudson-type tumor suppressor gene due to its low mutation rate in lung cancer.
    • Further investigation into p73 deregulation, including mutation, LOH, and imprinting, is warranted.